Legal & General Group Plc Trims Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)
Legal & General Group Plc reduced its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 5.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 14,439 shares of the company’s stock after selling 766 shares during the period. Legal & General Group Plc owned about […]
